SOCIETY PASS INCORPORATED. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SOCIETY PASS INCORPORATED. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $8.17M | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | $5.64M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $519.9K | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $52.5K | Mar 30, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $7.11M | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $8.17M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $5.64M | Apr 15, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.86M | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $2.47M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $967.0K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($190.8K) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($36.2K) | Mar 30, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($10.23M) | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | ($18.13M) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($33.79M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($34.86M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($3.83M) | Mar 30, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($9.32M) | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | ($17.96M) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($34.16M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($34.21M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($3.75M) | Mar 30, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $54.6K | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $55.6K | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $73.0K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $95.8K | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $165.5K | Mar 30, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.47M | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | ($13.91M) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($14.45M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($10.81M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($1.25M) | Mar 30, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $30.0K | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $219.2K | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $566.3K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $46.8K | Mar 23, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $21.28M | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $16.36M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $32.70M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $35.18M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $7.87M | Mar 30, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $23.69M | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $11.33M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $12.69M | Apr 15, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($2.14M) | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $5.31M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $20.35M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $32.43M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($10.41M) | Mar 30, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $81.8K | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $88.2K | Apr 16, 2025 |
| FY2021 | Dec 31, 2021 | $2.77M | Mar 30, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($110.16M) | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | ($99.27M) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($81.14M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($47.35M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($12.59M) | Mar 30, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $7.63M | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $3.63M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $18.93M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $23.26M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $506.7K | Mar 30, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (3) | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | (9) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | (1) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | (3) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 30, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (3) | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | (9) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | (1) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | (3) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 30, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 3.72M | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | 2.22M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | 27.08M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 19.73M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 7.41M | Mar 30, 2022 |